4 notes for clinicians on the newly revised immunization schedules

Immunization schedules have been revised for U.S. adults and children as of Feb. 10 for 2023 with new guidelines for COVID-19; measles, mumps and rubella; hepatitis B; and pneumococcal vaccination.

Advertisement

Aside from the addition of routine vaccination recommendations for both adults and children for COVID-19, the American Academy of Family Physicians published highlights from the new immunization schedules, including: 

  • Flu vaccination is recommended for everyone 65 and older, as well as those who are regularly in close contact with severely immunocompromised individuals.
  • A newly licensed measles, mumps and rubella vaccine, Priorix, was added to the table of trade names for vaccines. 
  • A newly licensed 15-valent pneumococcal conjugate vaccine, known as Vaxneuvance, was also added. 
  • A three-dose vaccine of PreHevbrio for prevention of hepatitis B was added, but is not recommended for pregnant individuals. 

Further information for clinicians about the immunization schedules can be found here.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.